Can an ancient herbal remedy deflate harmful gut cysts?
NCT ID NCT04368663
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This trial tests whether the traditional Japanese medicine TJ-134 can help people with symptomatic pneumatosis cystoides intestinalis, a condition where gas-filled cysts form in the intestinal wall. Participants receive either TJ-134 or lactomin daily for 8 weeks. The study measures changes in the cysts on CT scans and tracks symptoms like bloating and abdominal pain.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Keishi-ka-shakuyaku-daio-to (TJ-134), a traditional Japanese herbal medicine, compared with lactomin
- What this could lead to
- If effective, TJ-134 could offer a non-invasive treatment option for pneumatosis cystoides intestinalis, potentially reducing symptoms and the need for surgery.
- What could go wrong
- This is a small, early-stage trial, and the herbal medicine may not prove more effective than the comparison treatment. Possible side effects are not detailed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2020
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * typical findings of PCI on colonoscopy; Line or pebble like sessile cysts are distributed around the colon with normal overlying mucosa Exclusion Criteria: * patients can not take Keishi-ka-shakuyaku-daio-to(TJ-134)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pneumatosis cystoides intestinalis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Showa Inan General hospital
RECRUITINGKomagane, Nagano, 399-4117, Japan